Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Skape Bio ApS
APS
Active
Advertising protection
CVR 45471071
Ole Maaløes Vej 3, 2200
København N
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2025 · 1 year old
10 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Skape Bio ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-1M
-2M
-3M
-5M
-4M
2025
EBITDA
DKK millions
0M
-2M
-4M
-7M
-9M
-7M
2025
Income statement
DKK thousands
Item
2025
Gross profit
-3.586
Staff expenses
-3.683
EBITDA
-7.269
Depreciation & amort.
-0
EBIT
-7.269
Net financials
-290
Profit before tax
-7.560
Tax
-1.114
Net profit
-6.445
Balance sheet
DKK thousands
Item
2025
Total assets
36.082
Equity
-6.405
Long-term debt
41.767
Short-term debt
717
Total debt
42.484
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-726908800.0%
This company
2025
2025
Equity ratio
-17.8%
This company
38.2%
Market median
-147% vs market
2025
2025
Return on equity
-644502300.0%
This company
18.4%
Market median
-3502729991% vs market
2025
2025
Net profit margin (of gross profit)
-644502300.0%
This company
2025
2025
Asset turnover (of gross profit)
-0.10×
This company
2025
2025
Debt / equity
6.63×
This company
0.62×
Market median
-969% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-03-13 – 2025-12-31
View
PDF
More on Skape Bio ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
